Amylyx Pharmaceuticals, Inc. (AMLX) › RevenueAmylyx Pharmaceuticals, Inc. (AMLX) — RevenueAnnual figures by period end, from SEC filings.2022-12-31: $22.23M2023-12-31: $380.79M2024-12-31: $87.37M2025-12-31: $0$02022-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$0-100.0%2026-03-03From 2025-01-012024-12-31$87.37M-77.1%2026-03-03From 2024-01-012023-12-31$380.79M+1612.9%2025-03-04From 2023-01-012022-12-31$22.23M—2024-02-22From 2022-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)